Needham analyst Mayank Tandon maintains LendingTree (NASDAQ:TREE) with a Buy and raises the price target from $32 to $45.
Expert Outlook: Halozyme Therapeutics Through The Eyes Of 4 Analysts
Halozyme Therapeutics (NASDAQ:HALO) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from…